<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-07513R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0005159</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Neuroscience</subject><subject>Non-Clinical Medicine</subject><subject>Neurological Disorders/Cognitive Neurology and Dementia</subject></subj-group></article-categories><title-group><article-title>Beneficial Effects of Estrogen in a Mouse Model of Cerebrovascular Insufficiency</article-title><alt-title alt-title-type="running-head">Beneficial Effects of Estrogen</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Kitamura</surname><given-names>Naohito</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Araya</surname><given-names>Runa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kudoh</surname><given-names>Moeko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kishida</surname><given-names>Haruo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kimura</surname><given-names>Tetsuya</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Murayama</surname><given-names>Miyuki</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Takashima</surname><given-names>Akihiko</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sakamaki</surname><given-names>Yuriko</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hashikawa</surname><given-names>Tsutomu</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ito</surname><given-names>Shingo</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ohtsuki</surname><given-names>Sumio</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Terasaki</surname><given-names>Tetsuya</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wess</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yamada</surname><given-names>Masahisa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Yamada Research Unit, RIKEN Brain Science Institute, Saitama, Japan</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Laboratory for Alzheimer's Diseases, RIKEN Brain Science Institute, Saitama, Japan</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Research Resource Center, RIKEN Brain Science Institute, Saitama, Japan</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Molecular Biopharmacy and Genetics, Tohoku University, Sendai, Japan</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Cookson</surname><given-names>Mark R.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">National Institutes of Health, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>masahisa@brain.riken.jp</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: MY. Performed the experiments: NK RA MK HK TK MM AT YS SI SO. Analyzed the data: TK TH JW. Contributed reagents/materials/analysis tools: TT. Wrote the paper: JW MY.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>9</day><month>4</month><year>2009</year></pub-date><volume>4</volume><issue>4</issue><elocation-id>e5159</elocation-id><history><date date-type="received"><day>27</day><month>11</month><year>2008</year></date><date date-type="accepted"><day>5</day><month>3</month><year>2009</year></date></history><copyright-statement>This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.</copyright-statement><copyright-year>2009</copyright-year><abstract><sec><title>Background</title><p>The M<sub>5</sub> muscarinic acetylcholine receptor is known to play a crucial role in mediating acetylcholine dependent dilation of cerebral blood vessels. Previously, we reported that male M<sub>5</sub> muscarinic acetylcholine knockout mice (<italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice) suffer from a constitutive constriction of cerebral arteries, reduced cerebral blood flow, dendritic atrophy, and short-term memory loss, without necrosis and/or inflammation in the brain.</p></sec><sec><title>Methodology/Principal Findings</title><p>We employed the Magnetic Resonance Angiography to study the area of the basilar artery in male and female <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice. Here we show that female <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice did not show the reduction in vascular area observed in male <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice. However, ovariectomized female <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice displayed phenotypic changes similar to male <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice, strongly suggesting that estrogen plays a key role in the observed gender differences. We found that 17&#x003b2;-estradiol (E2) induced nitric oxide release and ERK activation in a conditional immortalized mouse brain cerebrovascular endothelial cell line. Agonists of ER&#x003b1;, ER&#x003b2;, and GPR30 promoted ERK activation in this cell line. Moreover, <italic>in vivo</italic> magnetic resonance imaging studies showed that the cross section of the basilar artery was restored to normal in male <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice treated with E2. Treatment with E2 also improved the performance of male <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice in a cognitive test and reduced the atrophy of neural dendrites in the cerebral cortex and hippocampus. <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice also showed astrocyte swelling in cortex and hippocampus using the three-dimensional reconstruction of electron microscope images. This phenotype was reversed by E2 treatment, similar to the observed deficits in dendrite morphology and the number of synapses.</p></sec><sec><title>Conclusions/Significance</title><p>Our findings indicate that <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice represent an excellent novel model system to study the beneficial effects of estrogen on cerebrovascular function and cognition. E2 may offer new therapeutic perspectives for the treatment of cerebrovascular insufficiency related memory dysfunction.</p></sec></abstract><counts><page-count count="13"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Cholinergic pathways have been shown to play an important role in the regulation of cerebral vascular resistance, relaxation and contraction of blood vessels, and regional blood flow <xref ref-type="bibr" rid="pone.0005159-Faraci1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005159-Sato1">&#x0005b;3&#x0005d;</xref>. It is well known that acetylcholine (Ach) is a powerful dilator of most vascular beds and that this activity is mediated by endothelial muscarinic Ach receptors triggering the release of the actual vasorelaxing agent, nitric oxide (NO) <xref ref-type="bibr" rid="pone.0005159-Furchgott1">&#x0005b;4&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005159-Sobey1">&#x0005b;8&#x0005d;</xref>. In a previous study, we demonstrated that M<sub>5</sub> receptors (M5R) mediate Ach-induced relaxation of cerebral but not of peripheral blood vessels <xref ref-type="bibr" rid="pone.0005159-Yamada1">&#x0005b;9&#x0005d;</xref>, consistent with immunohistochemical <xref ref-type="bibr" rid="pone.0005159-Tayebati1">&#x0005b;10&#x0005d;</xref> and pharmacological studies <xref ref-type="bibr" rid="pone.0005159-Hamel1">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Wang1">&#x0005b;12&#x0005d;</xref>.</p><p>Ach binding to M5Rs leads to the activation of G proteins of the Gq family which in turns triggers increases in intracellular calcium and inositol 1,4,5-triphosphate levels <xref ref-type="bibr" rid="pone.0005159-Bonner1">&#x0005b;13&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005159-Eglen1">&#x0005b;16&#x0005d;</xref> and eventually the activation of endothelial NO synthase (eNOS) and the production of NO <xref ref-type="bibr" rid="pone.0005159-Wang1">&#x0005b;12&#x0005d;</xref>. Therefore, the constitutive constriction of cerebral arteries in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice that we observed in a previous study <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref> is most likely due to the lack of Ach-mediated NO release.</p><p>We previously reported that male M5R knockout (<italic>M5R<sup>&#x02212;/&#x02212;</sup></italic>) mice show a constitutive decrease in the diameter of the basilar artery and of middle cerebral arterioles, a reduction in cerebral blood flow (CBF), and impaired autoregulation of CBF, as compared to wildtype littermates <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. Male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice also displayed dendritic atrophy in the cerebral cortex and hippocampus and impaired function of CA3 hippocampal pyramidal cells, probably secondary to cerebrovascular insufficiency <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. Moreover, deficits in short-term memory (Y-maze) and cognitive behavior (object recognition) were evident in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, consistent with impaired hippocampal function <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. These data suggest that male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice are a suitable model for evaluating the effect of decreased CBF on neurologic function. Numerous animal models of chronic cerebral hypoperfusion have been generated by surgical methods. For example, one of these models showed white matter lesions, glial activation, and spatial memory deficits, mimicking several pathological aspects of human ischemia <xref ref-type="bibr" rid="pone.0005159-Shibata1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Shibata2">&#x0005b;19&#x0005d;</xref>. Male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice show also prolonged chronic cerebral hypoperfusion without necrosis in brain <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>.</p><p>In the present study, we show that the phenotypic changes displayed by the male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice were absent in female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. One possibility is that estrogens, the primary female sex hormones, protect female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice against the detrimental effects associated with the lack of M5Rs in males. Consistent with this notion, several studies have shown that estrogen increases CBF by stimulating the release of NO from vascular endothelial cells <xref ref-type="bibr" rid="pone.0005159-Haynes1">&#x0005b;20&#x0005d;</xref>.</p><p>To test the hypothesis that estrogen protects against cerebrovascular and neuronal deficits caused by the absence of M5Rs, we conducted phenotyping studies with male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice bearing estrogen (E2) implants. We found that E2 treatment fully restored the diameter of the basilar artery to normal in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. Furthermore, treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice with estrogen also improved their cognitive performance in a Y-maze test and reduced the atrophy of neural dendrites in the cerebral cortex and hippocampus.</p><p>This study demonstrates that male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, but not female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, show a significantly increased number of GFAP positive cells in cortex and hippocampus, but the number of S100&#x003b2; positive astrocytes, a measure of the total number of astrocytes, remain unchanged. These astrocytic responses are unlikely associated with neural cells death or immunoglobulin <italic>leakage</italic> around cerebral blood vessels. This observation suggests that the lack of M5R in male mice leads to astrocytic swelling in cortex and hippocampus. Interestingly, E2 treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice completely restored normal GFAP expression levels in hippocampus. These findings indicate that <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice represent an excellent novel model system to study the beneficial effects of estrogen on cerebrovascular function and cognition.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Gender difference of CBF in <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice</title><p>We employed the Magnetic Resonance Angiography (MRA) based time-of flight (TOF) method to study the area of the basilar artery in male and female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. Ovariectomies were performed 4 month after birth using standard surgical procedures. To synchronize menstrual cycle length, we inject pregnant mare serum gonadotropin (PMSG) / human chorionic gonadotropin (hCG) into female mice by intraperitoneal injection (IP) before E2 treatment (see <xref ref-type="sec" rid="s4">Material and Method</xref> section). MRA was carried out 2 week after ovariectomy (OVX) surgery and two days after PMSG/hCG treatments on 4 month-old female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;11) and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (n&#x0200a;&#x0003d;&#x0200a;12). TOF angiograms were obtained using a two-dimensional gradient-echo sequence (for additional experimental details, see <xref ref-type="sec" rid="s4">Materials and methods</xref>). Three-dimensional angiograms of the MCA and the basilar artery (the segments indicated in <xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1A</bold></xref>) were obtained by using MATLAB software. <xref ref-type="fig" rid="pone-0005159-g001">Figure 1A</xref> shows that the diameter of the MCA and the basilar artery was similar in female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. In contrast, ovariectomized female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed a significant decrease in vascular diameter in the MCA and the basilar artery, as compared to intact female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1A</bold></xref>).</p><fig id="pone-0005159-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005159.g001</object-id><label>Figure 1</label><caption><title>Gender-specific phenotypic differences displayed by <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice.</title><p>(A) First, rapid scanning for the basilar artery provide the each portion of artery (left image; 3D angiograms of the basilar artery from female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice). Second, the vascular area of each portion of the basilar artery was measured by the high resolution imaging within 30 min on a perpendicular section of the vessel (the site where the basilar artery enters the circle of Wills), and mean vascular area was determined as the average of the 7 segments on the measured area of each 100 &#x000b5;m intervals (right image). Ovariectomies were performed 4 months after birth using standard surgical procedures. To synchronize menstrual cycle length, we injected pregnant mare serum gonadotropin (PMSG)/human chorionic gonadotropin (hCG) into female mice by IP injection before E2 treatment (see <xref ref-type="sec" rid="s4">Materials and Methods</xref> section). MRA was carried out 2 weeks after OVX surgery and two days after PMSG/hCG treatment on 4 month-old female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;11) and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;12) mice. Values are means&#x000b1;SE. &#x0002a;<italic>p</italic>&#x0003c;0.05. (B) Morphologic changes of cortical pyramidal neurons (layer V) from OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. Golgi staining studies revealed that cortical pyramidal neurons from OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed clear signs of atrophy of the basal-dendritic tree and apical dendrites. White scale bars in upper panels, 50 &#x000b5;m; black scale bars in lower panels, 10 &#x000b5;m. (C) Performance of female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic>mice, as well as OVX <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and OVX <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, in the Y-maze spontaneous alternation task. Note that only OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed a performance deficit in this test. Data are given as means&#x000b1;SEM; female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic>, n&#x0200a;&#x0003d;&#x0200a;11 mice; female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic>, n&#x0200a;&#x0003d;&#x0200a;12 mice OVX female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic>, n&#x0200a;&#x0003d;&#x0200a;20 mice; OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic>, n&#x0200a;&#x0003d;&#x0200a;20 mice; &#x0002a;<italic>p</italic>&#x0003c;0.05.</p></caption><graphic xlink:href="pone.0005159.g001"/></fig><p>For CBF measurements, we defined the branches of the MCA in the order from A1 to A3 (data not shown) and previously described in <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. We measured the CBF of cerebral arterioles located on the cortical surface at the level of the peripheral branch of the MCA in male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (4-month-old) using laser-Doppler flowmeter. Under resting conditions, male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed a significantly lower (<italic>p</italic>&#x0003c;0.001) CBF than male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice at the A1 branch (see Supporting Information, <xref ref-type="supplementary-material" rid="pone.0005159.s001"><bold>Figure S1</bold></xref>). However, female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice did not show any significant impairment in CBF, as compared to female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (<xref ref-type="supplementary-material" rid="pone.0005159.s001"><bold>Figure S1</bold></xref>). Furthermore, OVX <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed impaired CBF (<italic>p</italic>&#x0003c;0.001), similar to male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="supplementary-material" rid="pone.0005159.s001"><bold>Figure S1</bold></xref>), suggesting that female sex hormones, such as estrogen, may be able to compensate for the impairment of cerebrovascular function caused by the lack of M5Rs in male mice.</p></sec><sec id="s2b"><title>Neuroanatomical and cognitive phenotypes of female and OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice</title><p>Male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed a significantly reduced number of dendritic spines in cortical and hippocampal CA3 pyramidal neurons <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. We therefore also examined the number of dendritic spines in cortical pyramidal neurons (layer V) from female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. Golgi staining studies revealed that cortical pyramidal neurons from female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (4-month-old) showed no clear signs of atrophy of the basal-dendritic tree and apical dendrites (<xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1B</bold></xref>). However, OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (4-month-old) showed a similar phenotype as male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1B</bold></xref>). Immunostaining experiments were carried out 2 weeks after OVX surgery and two days after PMSG/hCG treatment on 4 month-old females. The number of spines in basal dendrites was significantly reduced in OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, as compared with OVX female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1B</bold></xref>) (number of spines per 10 &#x000b5;m length of dendritic segment: OVX female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, 24.4&#x000b1;0.3; OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, 18.1&#x000b1;0.9; means&#x000b1;SEM; P&#x0003c;0.05; n&#x0200a;&#x0003d;&#x0200a;40 dendritic segments from 3 animals per group). We also analyzed the expression of several key neuronal receptor proteins by using western blot analysis (cerebral cortex and hippocampus). Specifically, we examined the expression levels of the NR1 &#x0005b;N-methyl-D-aspartate (NMDA) receptor subunit&#x0005d;, GluR1 (AMPA receptor subunit), and GluR5 (kainate receptor subunit) glutamate receptor subunits. We did not observe any significant differences in glutamate receptor expression levels between female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (4-month-old) (<xref ref-type="supplementary-material" rid="pone.0005159.s002"><bold>Figure S2</bold></xref>). However, OVX female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (4-month-old) showed significantly reduced expression levels of NR1 and GluR5 receptors in cortex and hippocampus (<italic>p</italic>&#x0003c;0.05; <xref ref-type="supplementary-material" rid="pone.0005159.s002"><bold>Figure S2</bold></xref>) and reduced expression of GluR1 in cortex, as compared to OVX female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice. GluR1 expression levels in hippocampus remained unaffected (<xref ref-type="supplementary-material" rid="pone.0005159.s002"><bold>Figure S2</bold></xref>).</p><p>We next examined short time memory in female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, using the Y-maze spontaneous alternation task <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. We found that locomotor activity did not differ significantly between the four groups (female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, OVX female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice; data not shown). The Y-maze test was carried out 2 weeks after OVX surgery and two days after PMSG/hCG treatment on 4 month-old females. In the Y-maze task, female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (4-month-old) showed no significant impairments in spatial memory (<xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1C</bold></xref>). However, OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (4-month-old) showed impaired spontaneous alternation performance, similar to the male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref> (<italic>p</italic>&#x0003c;0.05; <xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1C</bold></xref>).</p></sec><sec id="s2c"><title>Mitogen-activated protein kinase (MAPK) activation and NO release by a muscarinic agonist and E2 in TM-BBB cells</title><p>17&#x003b2;-estradiol (E2), the primary estrogen, has been reported to signal rapidly through ERK/MAP kinase <xref ref-type="bibr" rid="pone.0005159-Chen1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005159-Vivacqua1">&#x0005b;23&#x0005d;</xref> and PI3K/Akt <xref ref-type="bibr" rid="pone.0005159-Haynes1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Oishi1">&#x0005b;24&#x0005d;</xref> to induce eNOS activity and NO generation in peripheral blood vessel derived cells <xref ref-type="bibr" rid="pone.0005159-Guo1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Kim1">&#x0005b;26&#x0005d;</xref> and in neuroblastoma cells <xref ref-type="bibr" rid="pone.0005159-Xia1">&#x0005b;27&#x0005d;</xref>. To examine the effect of estrogen on NO release in cerebral endothelial cells, we used the immortalized TM-BBB cell line, which is derived from mouse brain vascular endothelial cells <xref ref-type="bibr" rid="pone.0005159-Ohtsuki1">&#x0005b;28&#x0005d;</xref> (See <xref ref-type="sec" rid="s4">material and methods</xref>). TM-BBB cells were treated with bethanechol (Bch; 100 &#x000b5;M), a muscarinic receptor agonist, and E2 (10 nM) for 0&#x02013;60 min. Bch and E2 induced the phosphorylation of ERK1/2 in a similar manner (<xref ref-type="fig" rid="pone-0005159-g002"><bold>Figure 2A,B</bold></xref>). Moreover, both compounds stimulated NO production by &#x0223c;1.6-fold at the 180 min time point (<xref ref-type="fig" rid="pone-0005159-g002"><bold>Figure 2B</bold></xref>). These results support the concept that both muscarinic and estrogen receptor signaling leads to enhanced NO production via activation of eNOS through ERK 1/2 pathways in TM-BBB cells <xref ref-type="bibr" rid="pone.0005159-Prossnitz1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005159-Grossini1">&#x0005b;31&#x0005d;</xref>.</p><fig id="pone-0005159-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005159.g002</object-id><label>Figure 2</label><caption><title>Bethanechol and E2 induce ERK phosphorylation and NO production in TM-BBB cells in a time-dependent manner.</title><p>(A) TM-BBB cells were stimulated with 100 &#x000b5;M of the muscarinic agonist, bethanechol (Bch), or 10 nM E2 for different periods of time (1&#x02013;60 min), and cell lysates were analyzed by western blotting with anti-pERK or anti-total ERK antibodies. The cumulative results of Western blot analysis are reported from three independent experiments (10 min after treatment with Bch or E2). Values are means&#x000b1;SEM. &#x0002a;<italic>p</italic>&#x0003c;0.05 (vs vehicle control). (B) TM-BBB cells were stimulated with 100 &#x000b5;M Bch or 10 nM E2 for different time periods. Subsequently, nitrite levels were measured in the culture medium. Values are means&#x000b1;SEM. &#x0002a;&#x0002a;<italic>p</italic>&#x0003c;0.001 (vs vehicle control).</p></caption><graphic xlink:href="pone.0005159.g002"/></fig><p>RT-PCR studies showed that TM-BBB cells express M5Rs but not M3Rs which are normally found on non-cerebral arteries <xref ref-type="bibr" rid="pone.0005159-Khurana1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Lamping1">&#x0005b;33&#x0005d;</xref>, as well as ER&#x003b1;, ER&#x003b2; and GPR30 estrogen receptors (<xref ref-type="fig" rid="pone-0005159-g003"><bold>Figure 3A</bold></xref>) (See <xref ref-type="sec" rid="s4">material and methods</xref>). Therefore, we also treated TM-BBB cells with selective estrogen receptor agonists, ER&#x003b1; (1,3,5-Tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole (10 &#x000b5;M PPT), ER&#x003b2; (10 &#x000b5;M DPN), and GPR30 (10 &#x000b5;M G1) for 60 min. Subsequently, cell lysates were prepared and analyzed by western blotting with anti-pERK or anti-total ERK antibodies. This analysis revealed the increased ERK1/2 phosphorylation mediated by 10 &#x000b5;M PPT, 10 &#x000b5;M DPN, or 10 &#x000b5;M G1 for 60 min (<xref ref-type="fig" rid="pone-0005159-g003"><bold>Figure 3B</bold></xref>).</p><fig id="pone-0005159-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005159.g003</object-id><label>Figure 3</label><caption><title>Agonists of ER&#x003b1;, ER&#x003b2;, and GPR30 promoted ERK activation in TM-BBB cells.</title><p>(A) RT-PCR analysis demonstrating the presence of transcripts of M<sub>3</sub> muscarinic receptor (226 bp), M<sub>5</sub> muscarinic receptor (230 bp), ER&#x003b1; estrogen receptor (453 bp), ER&#x003b2; estrogen receptor (204 bp) and GPR30 estrogen receptor (386 bp) in TM-BBB cells. (B) TM-BBB cells were stimulated with the estrogen receptor agonists, PPT (ER&#x003b1;), DPN (ER&#x003b2;), or G1 (GPR30) for 60 min, and cell lysates were analyzed by western blotting with anti-pERK or anti-total ERK antibodies.</p></caption><graphic xlink:href="pone.0005159.g003"/></fig></sec><sec id="s2d"><title>Restoration of normal cerebral artery diameter by E2 in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice</title><p>MRA experiments were carried out 2 weeks after OVX surgery and two days after PMSG/hCG treatment on 4 month-old females. <xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4B</bold></xref> shows that the diameter of the basilar artery was similar in female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (schematic representation of the E2 injection and MRA monitoring schedule, see <xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4A</bold></xref>). In contrast, OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed a significant decrease in vascular diameter, as compared to intact female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4B</bold></xref>). Moreover, treatment of OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice with E2 (1 &#x000b5;g E2 was injected into the tail vein) completely prevented these deficits (<xref ref-type="fig" rid="pone-0005159-g003"><bold>Figure 3B</bold></xref>). We noted that PMSG/hCG treatment did not significantly affect the diameter of the basilar artery in female mice (<xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4B</bold></xref>) and E2-treated male mice (<xref ref-type="supplementary-material" rid="pone.0005159.s003"><bold>Figure S3B</bold></xref>).</p><fig id="pone-0005159-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005159.g004</object-id><label>Figure 4</label><caption><title>E2 injection completely restores the cross-sectional area of the basilar artery in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice as well as in OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice.</title><p>(A) Schematic representation of the E2 injection and MRA monitoring schedule used. (B) Vascular area of the basilar artery in female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic>, <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic>, OVX <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic>, OVX <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic>, and E2 injected OVX <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic>and <italic>M5R</italic><sup>&#x02212;/&#x02212;</sup> mice. MRA was carried out 2 week after OVX surgery on 4 month-old female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;15) and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;15) mice. MRA was carried out 2 week after OVX surgery and two days after PMSG/hCG treatment on 4 month-old female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;14) and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;14) mice. After MRA analysis, 1 &#x000b5;g E2 was injected into the tail vein, followed by MRA 30 min after injection. Values are means&#x000b1;SE. &#x0002a;&#x0002a;<italic>p</italic>&#x0003c;0.001. (C) Vascular area of the basilar artery in male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic>and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice and E2 injected male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. 3.5&#x02013;4.5 month-old male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;6) and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;10) mice were used for MRA analysis and 1 &#x000b5;g E2 was injected into the tail vein, followed by MRA 30 min after injection. Values are means&#x000b1;SEM. &#x0002a;&#x0002a;<italic>p</italic>&#x0003c;0.001.</p></caption><graphic xlink:href="pone.0005159.g004"/></fig><p>As reported previously <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>, the diameter of the basilar artery was significantly reduced in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, as compared to male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4C</bold></xref>). Strikingly, E2 treatment (1 &#x000b5;g E2 was injected into the tail vein) of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice led to an increase in the diameter of the basilar artery, similar to that observed with control male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4C</bold></xref>). On the other hand, in male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, E2 injection had no significant effect on vascular diameter (<xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4C</bold></xref>).</p></sec><sec id="s2e"><title>Normalization of neurite atrophy and cognitive function by E2 treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice</title><p>We next examined whether the deficits displayed by male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice could be overcome by chronic (3 weeks) E2 treatment (an 0.1 mg E2 pellet was implanted in the neck). As expected <xref ref-type="bibr" rid="pone.0005159-Gao1">&#x0005b;34&#x0005d;</xref>, non-treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (4 months old mice) showed a significant decrease in the diameter of the basilar artery (<xref ref-type="fig" rid="pone-0005159-g005"><bold>Figure 5B</bold></xref>) (a schematic representation schedule of E2 tablet implantation and MRA monitoring is given in <xref ref-type="fig" rid="pone-0005159-g005"><bold>Figure 5A</bold></xref>). Strikingly, E2 treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice led to a recovery of vascular diameter, similar to that of control male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g005"><bold>Figure 5B</bold></xref>). PMSG/hCG treatment had not significant effect on the diameter of the basilar artery in male mice during transient or chronic E2 treatment experiments (<xref ref-type="supplementary-material" rid="pone.0005159.s003"><bold>Figure S3</bold></xref>).</p><fig id="pone-0005159-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005159.g005</object-id><label>Figure 5</label><caption><title>Chronic E2 treatment rescues cerebrovascular deficits in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice.</title><p>(A) A schematic representation schedule of E2 tablet implantation and MRA monitoring. (B) Chronic E2 treatment completely rescues cerebrovascular deficits in 3.5 month-old male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. After MRA, an E2 tablet (0.1 mg / 21 days release) was implanted into the neck of each mouse, followed by MRA testing 3 weeks after the start of E2 administration. (C) The increased NHE1 expression levels in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. Na<sup>&#x0002b;</sup>/H<sup>&#x0002b;</sup> exchanger isoform 1 (NHE1)is indicated by Red color. The GFAP is indicated by Green color. The site where the choroid plexus between fimbria of hippocampus and ventricle is indicated by arrows. Scale bar; 100 &#x000b5;m.</p></caption><graphic xlink:href="pone.0005159.g005"/></fig><p>Hypoxic conditions affect the pH of cerebral blood serum. However, the collection of cerebral blood serum for pH measurements is technically very difficult in mice. The Na<sup>&#x0002b;</sup>/H<sup>&#x0002b;</sup> exchanger isoform 1 (NHE1) is known to be essential for the maintenance and regulation of pH in cortical astrocytes <xref ref-type="bibr" rid="pone.0005159-Mellergard1">&#x0005b;35&#x0005d;</xref>. NHE1 is also known to slightly detectable in cortical neurons <xref ref-type="bibr" rid="pone.0005159-Mellergard1">&#x0005b;35&#x0005d;</xref>. We therefore examined NHE1 expression levels in astrocytes of fimbria hippocampus, an area enriched with GFAP positive astrocytes. If reduced CBF causes acidosis associated with hypoxia in the brain of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, NHE1 is predicted to be upregulated in cortical astrocytes <xref ref-type="bibr" rid="pone.0005159-Jung1">&#x0005b;36&#x0005d;</xref>. We demonstrated that NHE1 immunolabeling was abundantly associated with plasma membrane structures of choroid plexus between fimbria of hippocampus and cortex (<xref ref-type="fig" rid="pone-0005159-g005"><bold>Figure 5C</bold></xref>). In male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, the intensity of NHE1 immunostaining was markedly increased in GFAP positive astrocytes in fimbria hippocampus (<xref ref-type="fig" rid="pone-0005159-g005"><bold>Figure 5C</bold></xref>). E2 treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice restored normal NHE1 immunostaining, similar to that of control male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g005"><bold>Figure 5C</bold></xref>).</p></sec><sec id="s2f"><title>Normalization of astrocytic swelling in cortex and hippocampus by E2 treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice</title><p>Under hypoxic conditions, changes in estrogen levels can lead to astrocytic swelling in the brain <xref ref-type="bibr" rid="pone.0005159-Dodel1">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Mor1">&#x0005b;38&#x0005d;</xref>. On the basis of these findings, we studied the number and morphology of astrocytes in the cortex and hippocampus of E2 treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, as well as non-treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice. We found that non-treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed a significant increase in the number of GFAP positive cells in cortex (<xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4A</bold></xref>) and hippocampus (<xref ref-type="fig" rid="pone-0005159-g004"><bold>Figure 4A</bold></xref><bold>, </bold><xref ref-type="supplementary-material" rid="pone.0005159.s004"><bold>Figure S4A&#x02013;C</bold></xref>), but the number of S100&#x003b2; positive astrocytes, a measure of the total number of astrocytes, remained unchanged. Furthermore, GFAP positive astrocytes in non-treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed many astrocytic processes (<xref ref-type="supplementary-material" rid="pone.0005159.s004"><bold>Figure S4C</bold></xref>). However, male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice did not show migration of microglia (Iba-1 or Mac-2 positive cells) in cortex and hippocampus (<xref ref-type="supplementary-material" rid="pone.0005159.s004"><bold>Figure S4C</bold></xref>). To examine the intactness of the blood brain barrier (BBB), we injected 25 mg/kg Evans blue (EB) into the tail vain of 6-month-old male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, followed by visualization of auto-fluorescence of EB in cortical tissue <xref ref-type="bibr" rid="pone.0005159-Saria1">&#x0005b;39&#x0005d;</xref>. Since EB binds to albumin, red fluorescence of EB observed in tissue indicates leakage of blood vessels. Leakage of EB in surrounding blood vessels was not detected in cortex and hippocampus of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (<xref ref-type="supplementary-material" rid="pone.0005159.s004"><bold>Figure S4E</bold></xref>). These data suggest that astrocytic swelling in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> brain is unlikely to be associated with inflammation around cortical or hippocampal blood vessels. Moreover, non-treated female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice did not show a significant increase in the number of GFAP positive cells in cortex and hippocampus compared to female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (4 months old; <xref ref-type="fig" rid="pone-0005159-g006"><bold>Figure 6A</bold></xref>). However, 4-month-old OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed activated GFAP positive astrocytes in cortex and hippocampus (<xref ref-type="fig" rid="pone-0005159-g006"><bold>Figure 6A</bold></xref>), similar to male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g006"><bold>Figure 6B</bold></xref><bold>, </bold><xref ref-type="supplementary-material" rid="pone.0005159.s004"><bold>Figure S4A&#x02013;C</bold></xref>) (morphological analysis was carried out 2 weeks after OVX surgery on 4 month-old female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice), suggesting that female sex hormones, such as estrogen, may be able to compensate for the astrocyte activation caused by the impairment of cerebrovascular function. Strikingly, E2 treatment (an 0.1 mg E2 pellet was implanted in the neck) of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice restored normal GFAP expression levels (<xref ref-type="fig" rid="pone-0005159-g006"><bold>Figure 6B</bold></xref><bold>, </bold><xref ref-type="supplementary-material" rid="pone.0005159.s004"><bold>Figure S4B</bold></xref>). On the other hand, E2-treated male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> control mice showed similar levels of GFAP expression in cortex and hippocampus as non-treated <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g006"><bold>Figure 6B</bold></xref><bold>, </bold><xref ref-type="supplementary-material" rid="pone.0005159.s004"><bold>Figure S4A,B</bold></xref>).</p><fig id="pone-0005159-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005159.g006</object-id><label>Figure 6</label><caption><title>Male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice exhibit astrocyte swelling which is rescued by E2 treatment.</title><p>(A) Female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice exhibit GFAP immunoreactivity similar to female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice in the cortex and the CA3 region of hippocampus. Immunostaining experiments were carried out 2 weeks after OVX surgery and two days after PMSG/hCG treatment on 4 month-old females. OVX <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> female mice showed a significantly increased immunoreactivity of GFAP positive cells. Scale bar&#x0200a;&#x0003d;&#x0200a;1 mm. (B) GFAP immunostaining shows astrocyte activation in cortex and hippocampus in 4-month-old male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. However, E2 treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice restored normal GFAP expression levels. Frozen sections of the brain (coronal section) were prepared from male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice without or after chronic E2 treatment (3 weeks, 1 &#x000b5;g E2 was injected into the tail vein). For details, see the legend to <xref ref-type="fig" rid="pone-0005159-g003">Fig. 3D</xref>. Scale bar&#x0200a;&#x0003d;&#x0200a;1 mm. (C) Astrocytic swelling in the CA3 hippocampal astrocytes was visualized using three-dimensional reconstruction of electron microscope images. A total of 100&#x02013;110 sections of 70 nm electron microscope images were reconstructed to visualize astrocytic shapes.</p></caption><graphic xlink:href="pone.0005159.g006"/></fig><p>To exclude the possibility that E2 treatment upregulates GFAP gene expression levels in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, we carried out morphological studies on CA3 hippocampal astrocytes using three-dimensional reconstruction of electron microscope images (<xref ref-type="fig" rid="pone-0005159-g006"><bold>Figure 6C</bold></xref>). A total of 100&#x02013;110 sections of 70 nm electron microscope images were reconstructed to visualize astrocyte shapes (see three-dimensional reconstruction of electron microscope images in Supplemental movies; non-treated male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, <xref ref-type="supplementary-material" rid="pone.0005159.s005"><bold>Movie S1</bold></xref>; non-treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, <xref ref-type="supplementary-material" rid="pone.0005159.s006"><bold>Movie S2</bold></xref>; E2-treated male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, <xref ref-type="supplementary-material" rid="pone.0005159.s007"><bold>Movie S3</bold></xref>; E2-treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice <xref ref-type="supplementary-material" rid="pone.0005159.s008"><bold>Movie S4</bold></xref>). This analysis showed that the astrocyte activation leaded to the swollen astrocyte foot processes in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice were markedly reduced in E2-treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g006"><bold>Figure 6C</bold></xref>). It is therefore unlikely that E2 treatment leads to changes in <italic>gfap</italic> gene expression levels in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice.</p></sec><sec id="s2g"><title>Normalization of neural morphology in cortex and hippocampus by E2 treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice</title><p>We examined the effect of chronic (3 weeks) E2 treatment on astrocyte morphological changes. As expected, non-treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (4 months old) showed a significant reduction in spine number in cortical (<xref ref-type="fig" rid="pone-0005159-g007"><bold>Figure 7A,B</bold></xref>) and CA3 hippocampal pyramidal neurons (<xref ref-type="fig" rid="pone-0005159-g007"><bold>Figure 7C</bold></xref>), and synapse number in CA3 hippocampal pyramidal neurons (<xref ref-type="fig" rid="pone-0005159-g007"><bold>Figure 7D</bold></xref>). However, after 3 weeks of E2 treatment, these morphological deficits were greatly ameliorated (<xref ref-type="fig" rid="pone-0005159-g007"><bold>Figure 7A&#x02013;D</bold></xref>).</p><fig id="pone-0005159-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0005159.g007</object-id><label>Figure 7</label><caption><title>E2 restores normal morphology in cortical and hippocampal pyramidal neurons from male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice.</title><p>(A) Morphologic changes of cortical pyramidal neurons (layer V) from male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice without or after chronic E2 treatment (3 weeks). Golgi staining revealed that cortical pyramidal neurons from male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed clear signs of atrophy of the basal-dendritic tree and apical dendrites. E2 treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice showed a similar morphology of spines in the basal-dendritic tree and apical dendrites as <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> control mice. (B) Number of spines per 10 &#x000b5;m length of dendritic segment of cortical pyramidal neurons (layer V) from male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, and E2 treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice. N&#x0200a;&#x0003d;&#x0200a;40 dendritic segments from 5 animals per group. (C) Number of spines per 10 &#x000b5;m length of dendritic segment of CA3 hippocampal pyramidal neurons from male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, and E2 treated male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice. Hippocampal neurons from male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice exhibited a significantly reduced number of dendritic spines. E2 administration also restored the number of dendritic spines in the CA3 hippocampus. N&#x0200a;&#x0003d;&#x0200a;20 dendritic segments from 5 animals per group. Values are means&#x000b1;SEM. &#x0002a;&#x0002a;<italic>p</italic>&#x0003c;0.001. (D) The number of synapses per 10<sup>2</sup> &#x000b5;m was counted in the CA3 hippocampus by analyzing electron microscope images. A total of 100&#x02013;110 sections of 70 nm electron microscope images were counted for each sample. Values are means&#x000b1;SEM. &#x0002a;&#x0002a;<italic>p</italic>&#x0003c;0.001. (E) Performance of male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice prior to and after chronic E2 treatment in a Y-maze spatial-memory test. Chronic E2 tablet (0.1 mg / 21 days release) treatment completely rescues cerebrovascular and cognitive deficits in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. All studies were carried out with 3 month-old male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;16) and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> (n&#x0200a;&#x0003d;&#x0200a;14) mice. Values are means&#x000b1;SEM. &#x0002a;<italic>p</italic>&#x0003c;0.05, &#x0002a;&#x0002a;<italic>p</italic>&#x0003c;0.001.</p></caption><graphic xlink:href="pone.0005159.g007"/></fig><p>We also examined the effect of chronic E2 treatment on the performance of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> and <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice in the Y-maze spontaneous alternation test which is commonly employed to assess spatial working memory. As reported previously, male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (4 months old) showed pronounced deficits in spontaneous alternation performance (<italic>p</italic>&#x0003c;0.05; <xref ref-type="fig" rid="pone-0005159-g007"><bold>Figure 7D</bold></xref>), as compared to male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice. After chronic E2 treatment, male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice did no longer show any significant impairments in this task (<xref ref-type="fig" rid="pone-0005159-g007"><bold>Figure 7D</bold></xref>), indicating that E2 enhances cognitive function in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice.</p></sec></sec><sec id="s3"><title>Discussion</title><p>The therapeutic utility of estrogen in postischemic treatment paradigms has been studied using chronic cerebral hypoperfusion models. E2 administered after permanent middle cerebral artery occlusion or reversible middle cerebral artery occlusion reduces infarction size in ovariectomized female rats <xref ref-type="bibr" rid="pone.0005159-Yang1">&#x0005b;40&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005159-Yong1">&#x0005b;42&#x0005d;</xref>. In these studies, estrogen is thought to act as a cerebral vasodilator and to protect vascular integrity. However, surgically induced animal models of cerebral hypoperfusion also lead to neuronal death and inflammation <xref ref-type="bibr" rid="pone.0005159-Shibata1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Shibata2">&#x0005b;19&#x0005d;</xref>. It is therefore possible that the E2-mediated reduction of infarction size seen in these models may be caused by anti-inflammatory or anti-apoptotic activities of E2 <xref ref-type="bibr" rid="pone.0005159-Santizo1">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Jia1">&#x0005b;44&#x0005d;</xref>. Thus, <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice represent a novel genetic model of chronic cerebral hypoperfusion that can provide new insight into beneficial effects of estrogen in the absence of necrotic or inflammatory processes.</p><p>We demonstrated that male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice displayed a significantly increased immunostaining of GFAP positive cells in cortex and hippocampus, indicative of astrocytic activation. One possibility is that this defect is responsible for the dendritic atrophy and loss of neural functions in these regions displayed by male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. These findings suggest that male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice represent a novel model to study the physiological and pathophysiological roles of the central cholinergic vasodilator system in regulating CBF, reactive astrocytic swelling and cognitive processes.</p><p>Strikingly, the phenotypic changes displayed by male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice were not observed in female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, suggesting that female sex hormones might modulate CBF in female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. Consistent with this notion, we observed that estrogen (E2) was able to release NO from cerebral vascular endothelial cells (NO is predicted to trigger vasodilation and increase CBF).</p><p>To test the hypothesis that estrogen may rescue the phenotypic deficits displayed by male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, we implanted estrogen pellets in the dorsum of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, and initially performed MRA measurements on the basilar artery three weeks post-implantation. We found that the diameter of the basilar artery was restored to normal in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice treated with estrogen. Several studies have shown that M5Rs are expressed by cerebral endothelial cells <xref ref-type="bibr" rid="pone.0005159-Yamada1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Tayebati1">&#x0005b;10&#x0005d;</xref>. Estrogen receptors (ERs) have also been shown to be expressed by vascular endothelial and smooth muscle cells <xref ref-type="bibr" rid="pone.0005159-Karas1">&#x0005b;45&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-KimSchulze1">&#x0005b;46&#x0005d;</xref>. Estrogen binding to membrane-bound ERs can lead to the activation of G proteins such as Gs and Gq <xref ref-type="bibr" rid="pone.0005159-Chambliss1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Razandi1">&#x0005b;48&#x0005d;</xref>. M5Rs and ERs may therefore be linked to common signaling pathways in cerebral endothelial cells. The observed rapid activation of MAPKs by E2 in TM-BBB cells may therefore reflect the activation of membrane-bound ERs linked to G protein signaling pathways. Consistent with this concept, the novel membrane estrogen receptor GPR30 <xref ref-type="bibr" rid="pone.0005159-Prossnitz1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005159-Grossini1">&#x0005b;31&#x0005d;</xref> was also detected in the TM-BBB cell line (<xref ref-type="fig" rid="pone-0005159-g003"><bold>Figure 3A</bold></xref>). We found that PPT (an ER&#x003b1; agonist), DPN (an ER&#x003b2; agonist), and G1 (a GPR30 agonist) promoted ERK activation (<xref ref-type="fig" rid="pone-0005159-g003"><bold>Figure 3B</bold></xref>). Therefore, a combination of estrogen receptors, ER&#x003b1;, ER&#x003b2;, and GPR30, may allow for sufficient ERK1/2 phosphorylation.</p><p>E2-mediated NO production has been linked to vasodilation and is thought to involve stimulation of eNOS following rapid activation of phosphatidylinositol-3 kinase (PI3K)/Akt or MAPK signaling in different vascular tissues <xref ref-type="bibr" rid="pone.0005159-Haynes1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Chen1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Guo1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Sykov1">&#x0005b;49&#x0005d;</xref>.</p><p>In the present study, we demonstrated that OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, in contrast to non-OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice, suffer from a constitutive constriction of cerebral arteries, reduced CBF, dendritic atrophy (<xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1A</bold></xref>), and short-term memory loss (<xref ref-type="fig" rid="pone-0005159-g001"><bold>Figure 1C</bold></xref>). We also found that E2 injection completely restored the diameter of the basilar artery in OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (as compared to non-OVX female <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice). E2 partially restored the vascular area in OVX female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice (as compared to non-OVX female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice). In addition, E2 rescued the constitutive constriction of the basilar artery in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. These results suggest that estrogen (E2) can compensate for the lack of M5R-mediated vasodilation in cerebral blood vessels in <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice can therefore be used as novel model to examine the vasodilator effects of estrogen <italic>in vivo</italic>. Therefore, estrogen therapy may be clinically useful not only for female but also for male patients suffering from cerebrovascular deficits.</p><p>It is known that ischemia results in a marked reduction of tissue pH <xref ref-type="bibr" rid="pone.0005159-Rehncrona1">&#x0005b;50&#x0005d;</xref> and cerebral ischemia has been demonstrated to produce an intracellular acidosis in the ischemic core as well as in the ischemic penumbra <xref ref-type="bibr" rid="pone.0005159-Yao1">&#x0005b;51&#x0005d;</xref>. For example, the NHE1 is one of the major acid extrusion mechanisms after intracellular acidosis. NHE1 catalyzes the electroneutral exchange of H<sup>&#x0002b;</sup> and Na<sup>&#x0002b;</sup> ions across cellular membranes, thereby regulating the pH of the cytoplasm <xref ref-type="bibr" rid="pone.0005159-Orlowski1">&#x0005b;52&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Ma1">&#x0005b;53&#x0005d;</xref>. Therefore, expression of NHE1 is thought to protect cells from internal acidification and to regulate cell volume in response to hypoxia. We found significantly increased NHE1 expression levels in male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="fig" rid="pone-0005159-g005"><bold>Figure 5C</bold></xref>). Swollen astrocyte foot processes lead to changes in brain extracellular space volume, composition, and geometry in aged animals with severe learning impairment <xref ref-type="bibr" rid="pone.0005159-Sykov1">&#x0005b;49&#x0005d;</xref>. It is hypothesized that the degree of hippocampal learning impairment in aged animals is related to astrocyte swelling <xref ref-type="bibr" rid="pone.0005159-Sykov1">&#x0005b;49&#x0005d;</xref>. Therefore we speculated that hypoxic stimulation induced astrocyte activation might contribute to the changes of neural activity in brain of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. We found that the lack of M5Rs in male mice was associated with cortical and hippocampal astrocytic swelling and deficits in dendritic morphology. It is well known that changes in astrocyte function regulate synaptic transmission <xref ref-type="bibr" rid="pone.0005159-Slezak1">&#x0005b;54&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0005159-Ullian1">&#x0005b;57&#x0005d;</xref>. It is tempting to speculate that the astrocytic swelling phenotype observed with male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice is a consequence of cerebrovascular insufficiency. Strikingly, E2 treatment of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice led to a reversal of the astrocytic swelling phenotype, which can occupy extra-synaptic spaces (<xref ref-type="fig" rid="pone-0005159-g006"><bold>Figure 6C</bold></xref>), and restored normal numbers of dendritic spines of pyramidal neurons in cortical and hippocampal pyramidal neurons (<xref ref-type="fig" rid="pone-0005159-g007"><bold>Figure 7A&#x02013;D</bold></xref>). Treatment with E2 also improved the performance of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice in a cognitive test (Y-maze spontaneous alternation task)(<xref ref-type="fig" rid="pone-0005159-g007"><bold>Figure 7E</bold></xref>). Estrogen treatment did not affect GFAP expression levels in male <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> mice, as studied by western blotting analysis (<xref ref-type="supplementary-material" rid="pone.0005159.s004"><bold>Figure S4B</bold></xref>). It is therefore unlikely that E2 acts on astrocytes directly to reduce GFAP immunoreactivity. GFAP expression levels were strikingly correlated with NHE1 expression levels in astrocytes, probably as a consequence of the hypoxic state of the brain of male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. Our findings support the idea that E2 regulates important neuroprotective mechanisms <italic>in vivo</italic> by acting directly on endothelial cells and/or through glial cell intermediaries. Estrogen has been demonstrated to have numerous effects on glial cells and neurons. Besides affecting CBF by acting on vascular ERs, E2 may protect against neuronal damage through actions on glial cell activation <xref ref-type="bibr" rid="pone.0005159-Jung1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0005159-Dodel1">&#x0005b;37&#x0005d;</xref>. Furthermore, animal studies suggest that E2 has neuroprotective effects against excito-toxicity <xref ref-type="bibr" rid="pone.0005159-Woolley1">&#x0005b;58&#x0005d;</xref>, oxidative damage <xref ref-type="bibr" rid="pone.0005159-Green1">&#x0005b;59&#x0005d;</xref>, and cerebral ischemia <xref ref-type="bibr" rid="pone.0005159-Dubal1">&#x0005b;60&#x0005d;</xref>. Our observations support the concept that the beneficial effects of estrogen on neural function observed in the present study are due to cerebral vasodilation controlling astrocyte activation as well as a direct neuroprotective effect. Clearly, additional studies are needed to examine the causal relationship between the cerebrovascular, neuromorphological, and behavioral deficits displayed by male <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice and to further explore the mechanisms underlying the ability of estrogen to reverse these phenotypes.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Animals</title><p><italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice were produced as described previously <xref ref-type="bibr" rid="pone.0005159-Yamada1">&#x0005b;9&#x0005d;</xref>. The average menstrual cycle length is 4 days in mice. To synchronize menstrual cycle length, we injected pregnant mare serum gonadotropin (PMSG)/human chorionic gonadotropin (hCG) into female mice by intraperitoneal (IP) injection before E2 treatment. Female mice were primed with an IP injection of 7.5 IU of PMSG and 7.5 IU of hCG to induce ovulation. After two days, female mice were subjected to the experiments. Animal experiments were approved by the Animal Experiment Committee of the RIKEN Brain Science Institute.</p></sec><sec id="s4b"><title>Measurement of CBF using a laser Doppler flowmeter</title><p>CBF measurements were performed as previously described <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. The branches of the MCA were defined in the order from A1 to A3 <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. A probe with a diameter of 0.5 mm was attached to the point of divergence of the MCA, and CBF was measured continuously in the parietal lobe using a laser Doppler flowmeter (ALF 21, Advance Co., Ltd, Tokyo), in conjunction with a PowerLab system (AD Instruments, CA, USA).</p></sec><sec id="s4c"><title>MRA analysis</title><p>MRA was performed as previously described <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>, with minor modifications. Mice were anesthetized with pentobarbital and subjected to micro-MRI scans using a vertical bore 9.4 T Bruker AVANCE 400WB imaging spectrometer with a 250 mT/m actively shielded microimaging gradient insert (Bruker BioSpin GmbH, Ettlingen, Germany) <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. A 25-mm resonator was used for signal excitation and detection. The depth of anesthesia was monitored with a breathing sensor, and was maintained with 0.5 to 1.5&#x00025; isoflurane in air (2 l/min flow rate). Two-dimensional horizontal MRA images were acquired by using a method derived from gradient-echo pulse sequence with flow compensation. The scans were performed with the following imaging parameters: TR&#x0200a;&#x0003d;&#x0200a;50.0 ms; TE&#x0200a;&#x0003d;&#x0200a;5.0 ms; flip angle&#x0200a;&#x0003d;&#x0200a;25&#x000b0;; matrix&#x0200a;&#x0003d;&#x0200a;256&#x000b7;256; field of view&#x0200a;&#x0003d;&#x0200a;2&#x000b7;2 cm<sup>2</sup>; number of slices&#x0200a;&#x0003d;&#x0200a;40; slice thickness&#x0200a;&#x0003d;&#x0200a;0.05 mm; and total imaging time&#x0200a;&#x0003d;&#x0200a;51 min (10 averages). Angiograms were obtained by generating maximum intensity projections using Paravision software (Bruker BioSpin GmbH). Basilar arterial vascular area was measured on the perpendicular section of the vessel using OSIRIX software, and mean vascular dimension was determined as the average of 7 segments in the measured area (<xref ref-type="fig" rid="pone-0005159-g003">Fig. 3A</xref>).</p></sec><sec id="s4d"><title>Ovariectomy and E2 implantation</title><p>Ovariectomies were performed 4 months after birth using standard surgical procedures. MRA was carried out 2 weeks after OVX surgery on 4 month-old female <italic>M5R<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mice. For transient E2 treatment experiments, 1 &#x000b5;g E2 was injected into the tail vein. For the chronic administration (3 weeks) of estrogen pellets (steady-release pellet of an 0.1 mg 17&#x003b2;-estradiol pellet) to adult male mice, a small incision was made in the dorsal neck region for the insertion of the hormone pellet (Innovative Research) to maintain plasma estrogen levels ranging from 250 to 260 pg/mL, and the incision was closed with a wound clip under anesthesia. The doses used in these experiments were chosen based upon their ability to generate physiological serum concentrations <xref ref-type="bibr" rid="pone.0005159-Shibata2">&#x0005b;19&#x0005d;</xref>. Estrogen was below the level of detection prior to E2 treatment of male mice.</p></sec><sec id="s4e"><title>Cell culture</title><p>The conditionally immortalized mouse brain capillary endothelial cell line (TM-BBB) was performed as previously described <xref ref-type="bibr" rid="pone.0005159-Hosoya1">&#x0005b;61&#x0005d;</xref>. The culture medium used consisted of DMEM (Gibco, Carlsbad, CA) supplemented with 15 &#x000b5;g/ml endothelial cell growth factor (Roche Diagnostics, Indianapolis, IN), 100 U/ml benzylpenicillin potassium, 100 &#x000b5;g/ml streptomycin sulfate, and 10&#x00025; fetal bovine serum.</p></sec><sec id="s4f"><title>Immunoblotting</title><p>TM-BBB cells were seeded at a density of 6.5&#x000d7;10<sup>4</sup> cells per dish on collagen type I-coated 35-mm culture dishes (Becton Dickinson). After 48 h of culture, cells were incubated for 24 h in growth factor-free medium followed by 2 h incubation in serum-free fresh medium at 33 &#x000b0;C. TM-BBB cells were incubated at 33 &#x000b0;C with vehicle, bethanechol 100 &#x000b5;M (Bch: MP Biomedicals, Solon, OH) or 17-&#x003b2;-estradiol 10 nM (E2: Sigma Chemical Co.) as indicated. TM-BBB cells were also treated with selective activators of ER&#x003b1; (1,3,5-Tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole; PPT, Sigma), ER&#x003b2; (DPN, Tocris Bioscience), and GPR30 (G1, MERCK). Cells were rinsed with ice-cold phosphate-buffered saline (PBS) containing 0.5 mM Na3VO4 and then collected in 100 &#x000b5;l of lysis buffer (50 mM Tris-HCl, pH 7.5, containing 150 mM NaCl, 1&#x00025; Triton X-100, 1&#x00025; deoxycholate, 0.2 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM EGTA, 0.4 mM EDTA, 1 mg/ml of aprotinin and leupeptin, and 0.1 mg/ml of phenylmethylsulphonyl fluoride). Lysates were centrifuged at 10,000 g for 15 min at 4&#x000b0;C to remove insoluble material and normalized for protein content. Equal amounts of protein (20 &#x000b5;g) were separated by 10&#x00025; SDS&#x02013;PAGE, transferred to nitrocellulose membranes (Schleicher &#x00026; Schuell), probed with rabbit polyclonal phospho-p44/42 MAP kinase antibody or rabbit polyclonal p44/42 MAP kinase antibody (Cell Signaling Beverly, MA). Subsequently, the membranes were incubated with goat anti-rabbit IgG secondary antibodies (PerkinElmer Life Sciences Inc. Boston, MA).</p></sec><sec id="s4g"><title>RT-PCR</title><p>Total RNA was extracted from tissues derived from TM-BBB using Trizol reagent (GIBCO). After DNase treatment (2 units &#x000b5;l<sup>&#x02212;1</sup>; Ambion), total RNA (&#x02248;1 &#x000b5;g) was reverse-transcribed by using oligo (dT)16 primers and murine leukemia virus RT (Perkin&#x02013;Elmer), followed by PCR amplification of a DNA segment specific for each receptor gene (PCR conditions: 98&#x000b0;C for 2 min; 35 cycles of 98&#x000b0;C for 10 sec and 55&#x000b0;C for 30 sec; 72&#x000b0;C for 5 min). For PCR amplification for the ER alpha gene, <named-content content-type="gene">5&#x02032;-TGGCGCTCCATGGAACAC-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-CATCTCCAGGAGCAGGTC-3&#x02032;;</named-content> ER beta gene, <named-content content-type="gene">5&#x02032;-AAAGCCAAGAGAACCAGTGGGCAC-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-GCCAATCATGTGCACCAGTTCCTT-3&#x02032;</named-content>; GPR30 gene, <named-content content-type="gene">5&#x02032;-ATCTGGATGGCCTCAGTGTC-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-ACTATGTGGCCTGTCAAGGG-3&#x02032;</named-content>; M3 receptor gene, <named-content content-type="gene">5&#x02032;-ACCAAGACCACAGTAGCAGTG-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-CTCTCTACATCCATAGTCCC-3&#x02032;</named-content>; M5 receptor gene, <named-content content-type="gene">5&#x02032;-GTCTCCGTCATGACCATACTCTA-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-CCCGTTGTTGAGGTGCTTCTAC-3&#x02032;</named-content></p></sec><sec id="s4h"><title>Nitrite assay</title><p>NO production was determined by measuring nitrite accumulation in culture medium using the NO2/NO3 Assay Kit-FX (Dojindo Laboratories, Kumamoto, Japan) according to manufacturer's instructions. Briefly, TM-BBB cells were seeded at a density of 6&#x000d7;10<sup>4</sup> cells per dish on collagen type I-coated 24 well plates (IWAKI, Chiba, Japan). After 48 h of culture, cells were washed twice with phenol red-free and serum-free MEM (Gibco) followed by incubation in 300 &#x000b5;l of the same medium containing vehicle, Bch or E2. After this incubation period, 300 &#x000b5;l of medium were removed from each well and centrifuged at 1,000 g for 15 min at room temperature. Supernatants (80 &#x000b5;l aliquots) were mixed with 20 &#x000b5;l of Buffer solution (pH 7.6) and 10 &#x000b5;l of fluorescence reagent (2,3-Diaminonaphthalene) solution, followed by incubation for 30 min at room temperature. The reaction was terminated by the addition of 30 &#x000b5;l of Stop solution. Fluorescence was measured using a spectrofluorometer (ARVO MX, PerkinElmer Life Sciences Inc.), with excitation and emission wavelengths set at 355 and 460 nm, respectively</p></sec><sec id="s4i"><title>Immunohistochemistry and Golgi staining</title><p>Frozen cryosections (15 &#x000b5;m) were treated with 3&#x00025; H<sub>2</sub>O<sub>2</sub>, incubated with blocking buffer (PBS containing 0.01&#x00025; Triton and 1.5&#x00025; normal goat serum), and incubated overnight at 4&#x000b0;C with primary antibodies. Sections were incubated with secondary antibody in blocking buffer for 1 h at room temperature. The primary antibodies used were anti-GFAP Ab (DAKO), anti-Iba-1 (Wako, Japan), and anti-Mac-2 (American Type Culture Collection, USA). Secondary antibodies were alexa fluor 546 goat anti-mouse IgG (Molecular Probes) and alexa fluor 488 goat anti-rabbit IgG (Molecular Probes). Sections were counterstained with Hoechst (CALBIOCHEM). Golgi staining was performed essentially as described previously <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref></p></sec><sec id="s4j"><title>Electron microscopy</title><p>For electronmicroscopic observation of astrocytes in the CA3 region of the hippocampus, a <italic>M5R<sup>&#x02212;/&#x02212;</sup></italic> mouse and a wild-type control mouse were fixed 2.5&#x00025; glutaraldehyde and 4&#x00025; paraformaldehyde. After fixation, the tissue samples were postfixed with 1&#x00025; (w/v) osmium tetroxide in 0.1 M PB, dehydrated in a graded ethanol series, and embedded in epoxy resin (EPON812, TAAB, Aldermaston, UK). For electron microscopic observations, the brain was sectioned into a series of 100&#x02013;110 sections (70 nm thick) with an ultramicrotome (EM UC6, Leica, Heidelberg, Germany). Ultrathin sections were stained with uranyl acetate and lead citrate. Electron micrographs recorded on imaging plates through a JEM-1200EX electron microscope (JEOL DATUM LTD., Tokyo, Japan) were scanned and digitized by an FDL 5000 imaging system (Fuji Photofilm, Tokyo, Japan). To reconstruct 3D images of astrocytes, each series was aligned using sEM Align software and edges of astrocytic cytoplasm were traced using IGL Trace software based on ref. <xref ref-type="bibr" rid="pone.0005159-Cooney1">&#x0005b;62&#x0005d;</xref> (freely available at <ext-link ext-link-type="uri" xlink:href="http:// synapse-web.org/tools/reconstruct/reconstruct.stm">http:// synapse-web.org/tools/reconstruct/reconstruct.stm</ext-link>).</p></sec><sec id="s4k"><title>Y-maze test</title><p>The Y-maze task was performed essentially as described previously <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>.</p></sec><sec id="s4l"><title>Statistical Analysis</title><p>Data are expressed as mean&#x000b1;SEM. Statistical comparisons of CBF, nitrite, and MRA data were performed using Student's <italic>t</italic>-test or ANOVA. <italic>p</italic>&#x0003c;0.05 was considered to be statistically different.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0005159.s001"><label>Figure S1</label><caption><p>Gender-specific phenotypic differences in CBF displayed by M5R&#x02212;/&#x02212; mice. CBF was measured in the middle cerebral artery and arterioles (MCA). MCA branches were defined in the order from A1 to A3 for classification scheme, described <xref ref-type="bibr" rid="pone.0005159-Araya1">&#x0005b;17&#x0005d;</xref>. CBF was measured in the A1 area by laser-Doppler flowmetry. Male M5R&#x02212;/&#x02212; mice showed significantly reduced CBF, as compared to male M5R&#x0002b;/&#x0002b; mice. In contrast, female M5R&#x0002b;/&#x0002b; and M5R&#x02212;/&#x02212; mice displayed similar CBF. OVX female M5R&#x02212;/&#x02212; mice showed reduced CBF, similar to male M5R&#x02212;/&#x02212; mice. Data are expressed as CBF relative to M5R&#x0002b;/&#x0002b; (white bars). OVX mice were used for CBF measurements 4 weeks after surgery performed on 4-month-old female M5R&#x02212;/&#x02212; and M5R&#x0002b;/&#x0002b; mice. The numbers given in parentheses under the bars indicate the number of independent experiments (mice). Data are means&#x000b1;SEM. &#x0002a;&#x0002a;p&#x0003c;0.001 (vs M5R&#x0002b;/&#x0002b; mice).</p><p>(11.24 MB TIF</p></caption><media xlink:href="pone.0005159.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005159.s002"><label>Figure S2</label><caption><p>Gender-specific phenotypic differences displayed by female M5R&#x02212;/&#x02212; mice. Relative expression levels, determined by Western blot analysis, of cortical (top panel) and hippocampal (lower panel) glutamate receptor subunits in female M5R&#x02212;/&#x02212; and M5R&#x0002b;/&#x0002b; (&#x0200a;&#x0003d;&#x0200a;100&#x00025;) mice, and OVX M5R&#x02212;/&#x02212; and OVX M5R&#x0002b;/&#x0002b; (&#x0200a;&#x0003d;&#x0200a;100&#x00025;) mice. The numbers given in parentheses underneath the bars indicate the number of independent experiments (mice). Data represent means&#x000b1;SEM; &#x0002a;p&#x0003c;0.05; &#x0002a;&#x0002a;p&#x0003c;0.001.</p><p>(11.24 MB TIF)</p></caption><media xlink:href="pone.0005159.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005159.s003"><label>Figure S3</label><caption><p>PMSG/hCG treatment did not significantly affect the diameter of the basilar artery in male mice. (A) Experimental schedule for PMSG/hCG/E2 treatment experiments. (B) PMSG/hCG treatment did not affect the diameter of the basilar artery during transient or chronic E2 treatment experiments. All studies were carried out with 3 month-old male M5R&#x0002b;/&#x0002b; and M5R&#x02212;/&#x02212; mice (n&#x0200a;&#x0003d;&#x0200a;12 per group). Data represent means&#x000b1;SEM; &#x0002a;p&#x0003c;0.05; &#x0002a;&#x0002a;p&#x0003c;0.001.</p><p>(9.00 MB TIF)</p></caption><media xlink:href="pone.0005159.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005159.s004"><label>Figure S4</label><caption><p>Male M5R&#x02212;/&#x02212; mice exhibit astrocyte activation without migration of microglia. Frozen sections of cerebral cortex and hippocampus were prepared from 4-month-old male M5R&#x0002b;/&#x0002b; and M5R&#x02212;/&#x02212; mice. An E2 tablet (0.1 mg/21 days release) was implanted into neck of each mouse. (A) GFAP immunostaining signals in the hippocampal CA3 region from E2-treated male M5R&#x02212;/&#x02212; and M5R&#x0002b;/&#x0002b; mice vs. non-treated male M5R&#x02212;/&#x02212; mice. Scale bar&#x0200a;&#x0003d;&#x0200a;200 &#x000b5;m. (B) E2 treatment of male M5R&#x02212;/&#x02212; mice restored wild-type-like GFAP protein expression levels in the hippocampus, as studied by western blotting analysis. E2-treated male M5R&#x0002b;/&#x0002b; mice showed similar GFAP protein expression levels as non-treated male M5R&#x0002b;/&#x0002b; mice. Data are means&#x000b1;SEM (n&#x0200a;&#x0003d;&#x0200a;8 per group). &#x0002a;p&#x0003c;0.05 (vs M5R&#x0002b;/&#x0002b; mice). (C) Male M5R&#x02212;/&#x02212; mice showed a significantly increased number of GFAP positive cells in the CA3 region of the hippocampus. However, the number of S100&#x003b2; positive astrocytes, a measure of the total number of astrocytes, remained unchanged. Five hippocampal CA3 sections from 5 animals per group were analyzed. Values are means&#x000b1;SE. &#x0002a;&#x0002a;p&#x0003c;0.001. (D) Vimentin and neurocan, markers for injured astrocytes, did not show any increase in immunoreactivity in male M5R&#x02212;/&#x02212; mice. Scale bar, 1 mm. (E) Leakage of EB in surrounding blood vessels was not detected in cortex and hippocampus of male M5R&#x02212;/&#x02212; and M5R&#x0002b;/&#x0002b; mice. Scale bar, 1 mm.</p><p>(11.24 MB TIF)</p></caption><media xlink:href="pone.0005159.s004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005159.s005"><label>Movie S1</label><caption><p>(0.96 MB SWF)</p></caption><media xlink:href="pone.0005159.s005.swf" mimetype="application" mime-subtype="x-shockwave-flash"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005159.s006"><label>Movie S2</label><caption><p>(1.90 MB SWF)</p></caption><media xlink:href="pone.0005159.s006.swf" mimetype="application" mime-subtype="x-shockwave-flash"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005159.s007"><label>Movie S3</label><caption><p>(2.04 MB SWF)</p></caption><media xlink:href="pone.0005159.s007.swf" mimetype="application" mime-subtype="x-shockwave-flash"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0005159.s008"><label>Movie S4</label><caption><p>(1.85 MB SWF)</p></caption><media xlink:href="pone.0005159.s008.swf" mimetype="application" mime-subtype="x-shockwave-flash"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Drs. T. Noguchi and M. Yuhki for excellent technical support.</p></ack><ref-list><title>References</title><ref id="pone.0005159-Faraci1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faraci</surname><given-names>FM</given-names></name><name><surname>Sigmund</surname><given-names>CD</given-names></name></person-group><year>1999</year><article-title>Vascular biology in genetically altered mice: smaller vessels, bigger insight.</article-title><source>Circ Res</source><volume>85</volume><fpage>1214</fpage><lpage>1225</lpage><pub-id pub-id-type="pmid">10590250</pub-id></citation></ref><ref id="pone.0005159-Hotta1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hotta</surname><given-names>H</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name><name><surname>Kagitani</surname><given-names>F</given-names></name></person-group><year>2002</year><article-title>Effects of stimulating the nucleus basalis of Meynert on blood flow and delayed neuronal death following transient ischemia in the rat cerebral cortex.</article-title><source>Jpn J Physiol</source><volume>52</volume><fpage>383</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">12519473</pub-id></citation></ref><ref id="pone.0005159-Sato1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name></person-group><year>2004</year><article-title>Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat's cortex and hippocampus.</article-title><source>Neurosci Lett</source><volume>361</volume><fpage>90</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15135901</pub-id></citation></ref><ref id="pone.0005159-Furchgott1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furchgott</surname><given-names>RF</given-names></name><name><surname>Zawadzki J</surname><given-names>V</given-names></name></person-group><year>1980</year><article-title>The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.</article-title><source>Nature</source><volume>288</volume><fpage>373</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">6253831</pub-id></citation></ref><ref id="pone.0005159-Rosenblum1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenblum</surname><given-names>WI</given-names></name></person-group><year>1986</year><article-title>Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles.</article-title><source>Stroke</source><volume>17</volume><fpage>494</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">3715949</pub-id></citation></ref><ref id="pone.0005159-Huang1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>PL</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Mashimo</surname><given-names>H</given-names></name><name><surname>Bloch</surname><given-names>KD</given-names></name><name><surname>Moskowitz</surname><given-names>MA</given-names></name><etal/></person-group><year>1995</year><article-title>Hypertension in mice lacking the gene for endothelial nitric oxide synthase.</article-title><source>Nature</source><volume>377</volume><fpage>239</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">7545787</pub-id></citation></ref><ref id="pone.0005159-Meng1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Ayata</surname><given-names>C</given-names></name><name><surname>Hara</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>PL</given-names></name><etal/></person-group><year>1996</year><article-title>ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms.</article-title><source>Am J Physiol</source><volume>271</volume><fpage>H1145</fpage><lpage>H1150</lpage><pub-id pub-id-type="pmid">8853353</pub-id></citation></ref><ref id="pone.0005159-Sobey1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sobey</surname><given-names>CG</given-names></name><name><surname>Faraci</surname><given-names>FM</given-names></name></person-group><year>1997</year><article-title>Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.</article-title><source>Stroke</source><volume>28</volume><fpage>837</fpage><lpage>842</lpage><pub-id pub-id-type="pmid">9099205</pub-id></citation></ref><ref id="pone.0005159-Yamada1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Lamping</surname><given-names>KG</given-names></name><name><surname>Duttaroy</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><etal/></person-group><year>2001</year><article-title>Cholinergic dilation of cerebral blood vessels is abolished in M<sub>5</sub> muscarinic acetylcholine receptor knockout mice.</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>14096</fpage><lpage>14101</lpage><pub-id pub-id-type="pmid">11707605</pub-id></citation></ref><ref id="pone.0005159-Tayebati1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tayebati</surname><given-names>SK</given-names></name><name><surname>Di Tullio</surname><given-names>MA</given-names></name><name><surname>Tomassoni</surname><given-names>D</given-names></name><name><surname>Amenta</surname><given-names>F</given-names></name></person-group><year>2003</year><article-title>Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries.</article-title><source>Neuroscience</source><volume>122</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">14596861</pub-id></citation></ref><ref id="pone.0005159-Hamel1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamel</surname><given-names>E</given-names></name></person-group><year>2004</year><article-title>Cholinergic modulation of the cortical microvascular bed.</article-title><source>Prog Brain Res</source><volume>145</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">14650915</pub-id></citation></ref><ref id="pone.0005159-Wang1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SZ</given-names></name><name><surname>Zhu</surname><given-names>SZ</given-names></name><name><surname>el-Fakahany</surname><given-names>EE</given-names></name></person-group><year>1994</year><article-title>Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase.</article-title><source>J Pharmacol Exp Ther</source><volume>268</volume><fpage>552</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">7509388</pub-id></citation></ref><ref id="pone.0005159-Bonner1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonner</surname><given-names>TI</given-names></name><name><surname>Young</surname><given-names>AC</given-names></name><name><surname>Brann</surname><given-names>MR</given-names></name><name><surname>Buckley</surname><given-names>NJ</given-names></name></person-group><year>1988</year><article-title>The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.</article-title><source>Neuron</source><volume>1</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">3272174</pub-id></citation></ref><ref id="pone.0005159-Liao1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>CF</given-names></name><name><surname>Themmen</surname><given-names>AP</given-names></name><name><surname>Joho</surname><given-names>R</given-names></name><name><surname>Barberis</surname><given-names>C</given-names></name><name><surname>Birnbaumer</surname><given-names>M</given-names></name><etal/></person-group><year>1989</year><article-title>Molecular cloning and expression of a fifth muscarinic acetylcholine receptor.</article-title><source>J Biol Chem</source><volume>264</volume><fpage>7328</fpage><lpage>7337</lpage><pub-id pub-id-type="pmid">2540186</pub-id></citation></ref><ref id="pone.0005159-Reever1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reever</surname><given-names>CM</given-names></name><name><surname>Ferrari-DiLeo</surname><given-names>G</given-names></name><name><surname>Flynn</surname><given-names>DD</given-names></name></person-group><year>1997</year><article-title>The M5 (m5) receptor subtype: fact or fiction?</article-title><source>Life Sci</source><volume>60</volume><fpage>1105</fpage><lpage>1112</lpage><pub-id pub-id-type="pmid">9121354</pub-id></citation></ref><ref id="pone.0005159-Eglen1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eglen</surname><given-names>RM</given-names></name><name><surname>Nahorski</surname><given-names>SR</given-names></name></person-group><year>2000</year><article-title>The muscarinic M<sub>5</sub> receptor: a silent or emerging subtype?</article-title><source>Br J Pharmacol</source><volume>130</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">10780992</pub-id></citation></ref><ref id="pone.0005159-Araya1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Araya</surname><given-names>R</given-names></name><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Yuhki</surname><given-names>M</given-names></name><name><surname>Kitamura</surname><given-names>N</given-names></name><name><surname>Higuchi</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice.</article-title><source>Neurobiol Dis</source><volume>24</volume><fpage>334</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">16956767</pub-id></citation></ref><ref id="pone.0005159-Shibata1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Ohtani</surname><given-names>R</given-names></name><name><surname>Ihara</surname><given-names>M</given-names></name><name><surname>Tomimoto</surname><given-names>H</given-names></name></person-group><year>2004</year><article-title>White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion.</article-title><source>Stroke</source><volume>35</volume><fpage>2598</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">15472111</pub-id></citation></ref><ref id="pone.0005159-Shibata2"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Yamasaki</surname><given-names>N</given-names></name><name><surname>Miyakawa</surname><given-names>T</given-names></name><name><surname>Kalaria</surname><given-names>RN</given-names></name><name><surname>Fujita</surname><given-names>Y</given-names></name><etal/></person-group><year>2007</year><article-title>Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion.</article-title><source>Stroke</source><volume>38</volume><fpage>2826</fpage><lpage>2832</lpage><pub-id pub-id-type="pmid">17761909</pub-id></citation></ref><ref id="pone.0005159-Haynes1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>MP</given-names></name><name><surname>Sinha</surname><given-names>D</given-names></name><name><surname>Russell</surname><given-names>KS</given-names></name><name><surname>Collinge</surname><given-names>M</given-names></name><name><surname>Fulton</surname><given-names>D</given-names></name><etal/></person-group><year>2000</year><article-title>Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.</article-title><source>Circ Res</source><volume>87</volume><fpage>677</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">11029403</pub-id></citation></ref><ref id="pone.0005159-Chen1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Yuhanna</surname><given-names>IS</given-names></name><name><surname>Galcheva-Gargova</surname><given-names>Z</given-names></name><name><surname>Karas</surname><given-names>RH</given-names></name><name><surname>Mendelsohn</surname><given-names>ME</given-names></name><etal/></person-group><year>1999</year><article-title>Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen.</article-title><source>J Clin Invest</source><volume>103</volume><fpage>401</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">9927501</pub-id></citation></ref><ref id="pone.0005159-Zivadinovic1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zivadinovic</surname><given-names>D</given-names></name><name><surname>Watson</surname><given-names>CS</given-names></name></person-group><year>2005</year><article-title>Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells.</article-title><source>Breast Cancer Res</source><volume>7</volume><fpage>R130</fpage><lpage>R144</lpage><pub-id pub-id-type="pmid">15642162</pub-id></citation></ref><ref id="pone.0005159-Vivacqua1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vivacqua</surname><given-names>A</given-names></name><name><surname>Bonofiglio</surname><given-names>D</given-names></name><name><surname>Recchia</surname><given-names>AG</given-names></name><name><surname>Musti</surname><given-names>AM</given-names></name><name><surname>Picard</surname><given-names>D</given-names></name><etal/></person-group><year>2006</year><article-title>The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.</article-title><source>Mol Endocrinol</source><volume>20</volume><fpage>631</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">16239258</pub-id></citation></ref><ref id="pone.0005159-Oishi1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oishi</surname><given-names>A</given-names></name><name><surname>Ohmichi</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Mori-Abe</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>Medroxyprogesterone acetate attenuates estrogen-induced nitric oxide production in human umbilical vein endothelial cells.</article-title><source>Biochem Biophys Res Commun</source><volume>324</volume><fpage>193</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">15465001</pub-id></citation></ref><ref id="pone.0005159-Guo1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Razandi</surname><given-names>M</given-names></name><name><surname>Pedram</surname><given-names>A</given-names></name><name><surname>Kassab</surname><given-names>G</given-names></name><name><surname>Levin</surname><given-names>ER</given-names></name></person-group><year>2005</year><article-title>Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>19704</fpage><lpage>19710</lpage><pub-id pub-id-type="pmid">15764600</pub-id></citation></ref><ref id="pone.0005159-Kim1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Levin</surname><given-names>ER</given-names></name></person-group><year>2006</year><article-title>Estrogen signaling in the cardiovascular system.</article-title><source>Nucl Recept Signal</source><volume>4</volume><fpage>e013</fpage><pub-id pub-id-type="pmid">16862219</pub-id></citation></ref><ref id="pone.0005159-Xia1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Krukoff</surname><given-names>TL</given-names></name></person-group><year>2004</year><article-title>Estrogen induces nitric oxide production via activation of constitutive nitric oxide synthases in human neuroblastoma cells.</article-title><source>Endocrinology</source><volume>145</volume><fpage>4550</fpage><lpage>4557</lpage><pub-id pub-id-type="pmid">15242984</pub-id></citation></ref><ref id="pone.0005159-Ohtsuki1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohtsuki</surname><given-names>S</given-names></name><name><surname>Tachikawa</surname><given-names>M</given-names></name><name><surname>Takanaga</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><etal/></person-group><year>2002</year><article-title>The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain.</article-title><source>J Cereb Blood Flow Metab</source><volume>22</volume><fpage>1327</fpage><lpage>1335</lpage><pub-id pub-id-type="pmid">12439290</pub-id></citation></ref><ref id="pone.0005159-Prossnitz1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prossnitz</surname><given-names>ER</given-names></name><name><surname>Arterburn</surname><given-names>JB</given-names></name><name><surname>Smith</surname><given-names>HO</given-names></name><name><surname>Oprea</surname><given-names>TI</given-names></name><name><surname>Sklar</surname><given-names>LA</given-names></name><etal/></person-group><year>2008</year><article-title>Estrogen Signaling through the Transmembrane G Protein-Coupled Receptor GPR30.</article-title><source>Annu Rev Physiol</source><volume>70</volume><fpage>165</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">18271749</pub-id></citation></ref><ref id="pone.0005159-Haas1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>E</given-names></name><name><surname>Meyer</surname><given-names>MR</given-names></name><name><surname>Schurr</surname><given-names>U</given-names></name><name><surname>Bhattacharya</surname><given-names>I</given-names></name><name><surname>Minotti</surname><given-names>R</given-names></name><etal/></person-group><year>2007</year><article-title>Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis.</article-title><source>Hypertension</source><volume>49</volume><fpage>1358</fpage><lpage>1363</lpage><pub-id pub-id-type="pmid">17452498</pub-id></citation></ref><ref id="pone.0005159-Grossini1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grossini</surname><given-names>E</given-names></name><name><surname>Molinari</surname><given-names>C</given-names></name><name><surname>Mary</surname><given-names>DA</given-names></name><name><surname>Uberti</surname><given-names>F</given-names></name><name><surname>Caimmi</surname><given-names>PP</given-names></name><etal/></person-group><year>2008</year><article-title>Intracoronary genistein acutely increases coronary blood flow in anesthetized pigs through &#x003b2;-adrenergic mediated nitric oxide release and estrogenic receptors.</article-title><source>Endocrinology</source><volume>149</volume><fpage>2678</fpage><lpage>2687</lpage><pub-id pub-id-type="pmid">18202136</pub-id></citation></ref><ref id="pone.0005159-Khurana1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khurana</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name><name><surname>Kennedy</surname><given-names>RH</given-names></name><name><surname>Raufman</surname><given-names>JP</given-names></name></person-group><year>2005</year><article-title>Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M3 receptor-dependent.</article-title><source>Eur J Pharmacol</source><volume>517</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">15964566</pub-id></citation></ref><ref id="pone.0005159-Lamping1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lamping</surname><given-names>KG</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Nuno</surname><given-names>DW</given-names></name><name><surname>Faraci</surname><given-names>FM</given-names></name></person-group><year>2004</year><article-title>Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>24</volume><fpage>1253</fpage><lpage>1258</lpage><pub-id pub-id-type="pmid">15130910</pub-id></citation></ref><ref id="pone.0005159-Gao1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Dluzen</surname><given-names>DE</given-names></name></person-group><year>2001</year><article-title>Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.</article-title><source>Neuroscience</source><volume>103</volume><fpage>385</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">11246153</pub-id></citation></ref><ref id="pone.0005159-Mellergard1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mellergard</surname><given-names>YB</given-names></name><name><surname>Ouyang</surname><given-names>BK</given-names></name><name><surname>Siesjo</surname></name></person-group><year>1993</year><article-title>Intracellular pH regulation in cultured rat astrocytes in CO2/HCO3(&#x02212;)-containing media. Exp.</article-title><source>Brain Res</source><volume>95</volume><fpage>371</fpage><lpage>380</lpage></citation></ref><ref id="pone.0005159-Jung1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>YW</given-names></name><name><surname>Choi</surname><given-names>IJ</given-names></name><name><surname>Kwon</surname><given-names>TH</given-names></name></person-group><year>2007</year><article-title>Altered expression of sodium transporters in ischemic penumbra after focal cerebral ischemia in rats.</article-title><source>Neurosci Res</source><volume>59</volume><fpage>152</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">17662498</pub-id></citation></ref><ref id="pone.0005159-Dodel1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dodel</surname><given-names>RC</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Bales</surname><given-names>KR</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Paul</surname><given-names>SM</given-names></name></person-group><year>1999</year><article-title>Sodium salicylate and 17&#x003b2;-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A&#x003b2; (1&#x02013;40) and lipopolysaccharides.</article-title><source>J Neurochem</source><volume>73</volume><fpage>1453</fpage><lpage>1460</lpage><pub-id pub-id-type="pmid">10501189</pub-id></citation></ref><ref id="pone.0005159-Mor1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mor</surname><given-names>G</given-names></name><name><surname>Nilsen</surname><given-names>J</given-names></name><name><surname>Horvath</surname><given-names>T</given-names></name><name><surname>Bechmann</surname><given-names>I</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><etal/></person-group><year>1999</year><article-title>Estrogen and microglia: A regulatory system that affects the brain.</article-title><source>J Neurobiol</source><volume>40</volume><fpage>484</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">10453051</pub-id></citation></ref><ref id="pone.0005159-Saria1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saria</surname><given-names>A</given-names></name><name><surname>Lundberg</surname><given-names>JM</given-names></name></person-group><year>1983</year><article-title>Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues.</article-title><source>J Neurosci Methods</source><volume>8</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">6876872</pub-id></citation></ref><ref id="pone.0005159-Yang1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>SH</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Day</surname><given-names>AL</given-names></name><name><surname>Simpkins</surname><given-names>JW</given-names></name></person-group><year>2000</year><article-title>Estradiol exerts neuroprotective effects when administered after ischemic insult.</article-title><source>Stroke</source><volume>31</volume><fpage>745</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">10700514</pub-id></citation></ref><ref id="pone.0005159-McCullough1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCullough</surname><given-names>LD</given-names></name><name><surname>Alkayed</surname><given-names>NJ</given-names></name><name><surname>Traystman</surname><given-names>RJ</given-names></name><name><surname>Williams</surname><given-names>MJ</given-names></name><name><surname>Hurn</surname><given-names>PD</given-names></name></person-group><year>2001</year><article-title>Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke.</article-title><source>Stroke</source><volume>32</volume><fpage>796</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">11239204</pub-id></citation></ref><ref id="pone.0005159-Yong1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>HJ</given-names></name><name><surname>Zhang</surname><given-names>YF</given-names></name><name><surname>Yang</surname><given-names>QD</given-names></name><name><surname>Liao</surname><given-names>DF</given-names></name><etal/></person-group><year>2005</year><article-title>17beta-estradiol potentiates ischemia-reperfusion injury in diabetic ovariectomized female rats.</article-title><source>Brain Res</source><volume>1054</volume><fpage>192</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">16125684</pub-id></citation></ref><ref id="pone.0005159-Santizo1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santizo</surname><given-names>RA</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Koenig</surname><given-names>HM</given-names></name><name><surname>Pelligrino</surname><given-names>DA</given-names></name></person-group><year>2000</year><article-title>Effects of estrogen on leukocyte adhesion after transient forebrain ischemia.</article-title><source>Stroke</source><volume>9</volume><fpage>2231</fpage><lpage>2235</lpage><pub-id pub-id-type="pmid">10978057</pub-id></citation></ref><ref id="pone.0005159-Jia1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Alkayed</surname><given-names>NJ</given-names></name><name><surname>Wang</surname><given-names>MM</given-names></name><etal/></person-group><year>2009</year><article-title>Estrogen inhibits Fas-mediated apoptosis in experimental stroke.</article-title><source>Exp Neurol</source><volume>215</volume><fpage>48</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">18950622</pub-id></citation></ref><ref id="pone.0005159-Karas1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karas</surname><given-names>RH</given-names></name><name><surname>Patterson</surname><given-names>BL</given-names></name><name><surname>Mendelsohn</surname><given-names>ME</given-names></name></person-group><year>1994</year><article-title>Human vascular smooth muscle cells contain functional estrogen receptor.</article-title><source>Circulation</source><volume>89</volume><fpage>1943</fpage><lpage>1950</lpage><pub-id pub-id-type="pmid">8181116</pub-id></citation></ref><ref id="pone.0005159-KimSchulze1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim-Schulze</surname><given-names>S</given-names></name><name><surname>McGowan</surname><given-names>KA</given-names></name><name><surname>Hubchak</surname><given-names>SC</given-names></name><name><surname>Cid</surname><given-names>MC</given-names></name><name><surname>Martin</surname><given-names>MB</given-names></name><etal/></person-group><year>1996</year><article-title>Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells.</article-title><source>Circulation</source><volume>94</volume><fpage>1402</fpage><lpage>1407</lpage><pub-id pub-id-type="pmid">8822999</pub-id></citation></ref><ref id="pone.0005159-Chambliss1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chambliss</surname><given-names>KL</given-names></name><name><surname>Shaul</surname><given-names>PW</given-names></name></person-group><year>2002</year><article-title>Estrogen modulation of endothelial nitric oxide synthase.</article-title><source>Endocr Rev</source><volume>23</volume><fpage>665</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">12372846</pub-id></citation></ref><ref id="pone.0005159-Razandi1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Razandi</surname><given-names>M</given-names></name><name><surname>Pedram</surname><given-names>A</given-names></name><name><surname>Merchenthaler</surname><given-names>I</given-names></name><name><surname>Greene</surname><given-names>GL</given-names></name><name><surname>Levin</surname><given-names>ER</given-names></name></person-group><year>2004</year><article-title>Plasma membrane estrogen receptors exist and functions as dimmers.</article-title><source>Mol Endocrinol</source><volume>18</volume><fpage>2854</fpage><lpage>2865</lpage><pub-id pub-id-type="pmid">15231873</pub-id></citation></ref><ref id="pone.0005159-Sykov1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sykov&#x000e1;</surname><given-names>E</given-names></name><name><surname>Mazel</surname><given-names>T</given-names></name><name><surname>Hasen&#x000f6;hrl</surname><given-names>RU</given-names></name><name><surname>Harvey</surname><given-names>AR</given-names></name><name><surname>Simonov&#x000e1;</surname><given-names>Z</given-names></name><etal/></person-group><year>2002</year><article-title>Learning deficits in aged rats related to decrease in extracellular volume and loss of diffusion anisotropy in hippocampus.</article-title><source>Hippocampus</source><volume>12</volume><fpage>269</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">12000123</pub-id></citation></ref><ref id="pone.0005159-Rehncrona1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehncrona</surname><given-names>S</given-names></name></person-group><year>1985</year><article-title>Brain acidosis.</article-title><source>Ann Emerg Med</source><volume>14</volume><fpage>770</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">3927794</pub-id></citation></ref><ref id="pone.0005159-Yao1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Ginsberg</surname><given-names>MD</given-names></name><name><surname>Eveleth</surname><given-names>DD</given-names></name><name><surname>LaManna</surname><given-names>JC</given-names></name><name><surname>Watson</surname><given-names>BD</given-names></name><etal/></person-group><year>1995</year><article-title>Local cerebral glucose utilization and cytoskeletal proteolysis as indices of evolving focal ischemic injury in core and penumbra.</article-title><source>J Cereb Blood Flow Metab</source><volume>15</volume><fpage>398</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">7713997</pub-id></citation></ref><ref id="pone.0005159-Orlowski1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orlowski</surname><given-names>J</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year>2004</year><article-title>Diversity of the mammalian sodium/proton exchanger SLC9 gene family.</article-title><source>Pflugers Arch</source><volume>447</volume><fpage>549</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">12845533</pub-id></citation></ref><ref id="pone.0005159-Ma1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>E</given-names></name><name><surname>Haddad</surname><given-names>GG</given-names></name></person-group><year>1997</year><article-title>Expression and localization of Na&#x0002b;/H&#x0002b; exchangers in rat central nervous system.</article-title><source>Neuroscience</source><volume>79</volume><fpage>591</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">9200742</pub-id></citation></ref><ref id="pone.0005159-Slezak1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slezak</surname><given-names>M</given-names></name><name><surname>Pfrieger</surname><given-names>FW</given-names></name></person-group><year>2003</year><article-title>New roles for astrocytes: regulation of CNS synaptogenesis.</article-title><source>Trends Neurosci</source><volume>26</volume><fpage>531</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">14522145</pub-id></citation></ref><ref id="pone.0005159-Wang2"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lou</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Tian</surname><given-names>GF</given-names></name><name><surname>Peng</surname><given-names>WG</given-names></name><etal/></person-group><year>2006</year><article-title>Astrocytic Ca2&#x0002b; signaling evoked by sensory stimulation in vivo.</article-title><source>Nat Neurosci</source><volume>9</volume><fpage>816</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">16699507</pub-id></citation></ref><ref id="pone.0005159-Haydon1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haydon</surname><given-names>PG</given-names></name></person-group><year>2001</year><article-title>GLIA: listening and talking to the synapse.</article-title><source>Nat Rev Neurosci</source><volume>2</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">11256079</pub-id></citation></ref><ref id="pone.0005159-Ullian1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ullian</surname><given-names>EM</given-names></name><name><surname>Sapperstein</surname><given-names>SK</given-names></name><name><surname>Christopherson</surname><given-names>KS</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year>2001</year><article-title>Control of synapse number by glia.</article-title><source>Science</source><volume>291</volume><fpage>657</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">11158678</pub-id></citation></ref><ref id="pone.0005159-Woolley1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woolley</surname><given-names>CS</given-names></name><name><surname>McEwen</surname><given-names>BS</given-names></name></person-group><year>1994</year><article-title>Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism.</article-title><source>J Neurosci</source><volume>14</volume><fpage>7680</fpage><lpage>7687</lpage><pub-id pub-id-type="pmid">7996203</pub-id></citation></ref><ref id="pone.0005159-Green1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>PS</given-names></name><name><surname>Bishop</surname><given-names>J</given-names></name><name><surname>Simpkins</surname><given-names>JW</given-names></name></person-group><year>1997</year><article-title>17 &#x003b2;-estradiol exerts neuroprotective effects on SK-N-SH cells.</article-title><source>J Neurosci</source><volume>17</volume><fpage>511</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">8987774</pub-id></citation></ref><ref id="pone.0005159-Dubal1"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubal</surname><given-names>DB</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Rau</surname><given-names>SW</given-names></name><name><surname>Shughrue</surname><given-names>PJ</given-names></name><etal/></person-group><year>2001</year><article-title>Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury.</article-title><source>Proc Natl Acad Sci USA</source><volume>98</volume><fpage>1952</fpage><lpage>1957</lpage><pub-id pub-id-type="pmid">11172057</pub-id></citation></ref><ref id="pone.0005159-Hosoya1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hosoya</surname><given-names>K</given-names></name><name><surname>Tetsuka</surname><given-names>K</given-names></name><name><surname>Nagase</surname><given-names>K</given-names></name><name><surname>Tomi</surname><given-names>M</given-names></name><name><surname>Saeki</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene.</article-title><source>AAPS PharmSci</source><volume>2</volume><fpage>E27</fpage><pub-id pub-id-type="pmid">11741243</pub-id></citation></ref><ref id="pone.0005159-Cooney1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooney</surname><given-names>JR</given-names></name><name><surname>Hurlburt</surname><given-names>JL</given-names></name><name><surname>Selig</surname><given-names>DK</given-names></name><name><surname>Harris</surname><given-names>KM</given-names></name><name><surname>Fiala</surname><given-names>JC</given-names></name></person-group><year>2002</year><article-title>Endosomal compartments serve multiple hippocampal dendritic spines from a widespread rather than a local store of recycling membrane.</article-title><source>J Neurosci</source><volume>22</volume><fpage>2215</fpage><lpage>2224</lpage><pub-id pub-id-type="pmid">11896161</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported in part by Grants-in-Aid from the Ministry of Health, Labor and Welfare, and for Scientific Research, Japan. Priority Area16300116 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 